Brain Stimulation for Long COVID Symptoms

Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation

Recruiting Phase 2 Interventional Study
Long COVID Long COVID Syndrome Long COVID-19 Syndrome PASC PASC Post Acute Sequelae of COVID 19
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
University of New Mexico · Other
Who this trial is looking for

This trial is looking for people aged 18 to 80 who have symptoms of Long COVID, like brain fog, depression, or anxiety. Participants will receive a type of brain stimulation treatment and undergo various tests to monitor their progress.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am aged 18 to 80.
  • I have a diagnosis of Long COVID with ongoing symptoms.
  • I have brain fog or cognitive difficulties.
  • I am fluent in English.
  • If I take psychiatric medications, my doses have been stable for the past month.

You may not be able to join if

  • I have a history of other neurological diseases.
  • I have a history of seizures.
  • I have a history of a psychotic disorder.
  • I have ongoing substance or alcohol dependence.
  • I have any implanted electrical devices.
  • I have been hospitalized for medical reasons in the past four weeks.
  • I cannot complete the study tasks.
  • I am part of a vulnerable population, like a minor or pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to test whether a type of rapid outpatient brain stimulation that uses magnetic fields, called accelerated intermittent theta burst stimulation (iTBS), can treat symptoms such as brain fog, depression, and anxiety in patients with Long COVID. The main questions it aims to answer are: * Is iTBS effective and feasible for reducing Long COVID symptoms? We will meas…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. aged 18-80 2. a documented diagnosis of PASC with evidence of ongoing symptoms as demonstrated by score of 12 on the NIH RECOVER Symptom List 3. have "brain fog" or cognitive difficulties as one of the ongoing symptoms 4. are fluent in English 5. if taking psychotropic medica…
Contacts

Crystal Garcia

505-272-9552

crabaca@salud.unm.edu

CONTACT